Rainbow Children’s Medicare growth supported by 2,500-bed expansion despite near-term margin pressure

Investment View and Valuation

ICICI Securities retains a BUY recommendation on Rainbow Children’s Medicare Limited (RCML), with a target price of Rs 1,860 versus the CMP of Rs 1,560. The view is supported by RCML’s specialist position in paediatric multi-speciality and perinatal healthcare, strong operating track record and sizeable capacity expansion pipeline.

RCML operated 24 hospitals and five clinics across nine cities, with a total capacity of 2,435 beds. ICICI Securities considers the combination of paediatric and perinatal offerings—including neurology, nephrology, oncology and cardiology—a differentiating strength relative to peers.

The target price is based on a valuation of 25 times FY28E EBITDA of Rs 723 crore. The broker identifies the capex cycle and associated margin execution as key monitoring factors.

Q1FY27 Financial Performance

ICICI Securities characterised RCML’s Q1FY27 performance as a strong overall print. Operating income benefited from higher outpatient volumes and deliveries, while occupancy improved despite the addition of new capacity at Bengaluru spokes. The report does not provide a comparison of reported results with broker estimates.

EBITDA increased year-on-year, but EBITDA margin declined as expenses increased. PAT declined year-on-year, resulting in a lower PAT margin.

Operating Metrics and Hospital Maturity

For FY26, RCML reported blended ARPOB of Rs 60,141, occupancy of 46.3% and an average length of stay of 2.71 days. The payor mix comprised 52% insurance and 48% cash.

Mature hospitals, defined as facilities more than five years old, generated ARPOB of about Rs 70,000, compared with approximately Rs 59,000 for younger hospitals. Management expects ARPOB to improve as its facilities mature.

• Rajahmundry has reached near break-even.
• Electronic City, Bengaluru was expected to break even within two to three months.
• Greenfield hospitals generally target break-even within 15 to 18 months.

Capacity Expansion Pipeline

Management plans to reach 5,000 beds over five years by adding 2,500 beds, involving estimated investment of Rs 2,200 crore. Visibility exists on 1,200 beds at various stages of development.

• A 100-bed brownfield hospital in Malad, Mumbai is expected in Q1FY28.
• The Prime Children’s Hospital acquisition in Nellore will add 70 beds, along with a 30-bed maternity block.
• A 50-bed leased hospital is planned in Guntur.
• Indore is expected in Q3FY27.
• Coimbatore and Gurugram Sector 56 are expected in Q3FY28.
• Gurugram Sector 44, Pune and a Bengaluru spoke are scheduled for FY29.

Management expects the Mumbai market to support better pricing and ARPOB, with eventual EBITDA margins above 20%. RCML is also investing in CRM, digital patient acquisition, lead management, SAP and data infrastructure to reduce seasonality and improve patient conversion.

Financial Outlook

ICICI Securities expects revenue to grow from Rs 1,703.1 crore in FY26 to Rs 2,047.0 crore in FY27E and Rs 2,481.5 crore in FY28E. EBITDA margins are projected to moderate as expansion progresses.

Key Risks

• Attrition of trained staff and doctors.
• Significant dependence on a few geographic clusters.
• Execution of the capex cycle and the associated impact on margins.